Histiocytic and Dendritic Cell Neoplasms

Surgical Pathology Clinics

Volumn 3, Issue 4, 2010, Pages 1165-1183

  Jones, Dan ^a  

^a QUEST DIAGNOSTICS NICHOLS INSTITUTE   (United States)

Author keywords

Dendritic cells; Lineage infidelity; Lymph node sarcomas; Plasticity; Transdifferentiation

Indexed keywords

BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASM; CLINICAL FEATURE; DENDRITIC CELL; DIFFERENTIAL DIAGNOSIS; FOLLICULAR DENDRITIC SELL SARCOMA; GRANULOCYTIC SARCOMA; HISTIOCYTE; HISTIOCYTIC SARCOMA; HISTIOCYTOSIS; HUMAN; IMMUNOPHENOTYPING; MORPHOLOGY; NEOPLASM; PRIORITY JOURNAL; PROGNOSIS; REVIEW;

EID: 78649660857     PISSN: 18759181     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.path.2010.09.008     Document Type: Review

References (58)

1. Ito T., Liu Y.J., Kadowaki N. Functional diversity and plasticity of human dendritic cell subsets. Int J Hematol 2005, 81(3):188-196.
2. Tian F., Grimaldo S., Fugita M., et al. The endothelial cell-produced antiangiogenic cytokine vascular endothelial growth inhibitor induces dendritic cell maturation. J Immunol 2007, 179(6):3742-3751.
3. Angelot F., Seillès E., Biichlé S., et al. Endothelial cell-derived microparticles induce plasmacytoid dendritic cell maturation: potential implications in inflammatory diseases. Haematologica 2009, 94(11):1502-1512.
4. Asano S., Muramatsu T., Kanno H., et al. Dermatopathic lymphadenopathy. Electron microscopic, enzyme-histochemical and immunohistochemical study. Acta Pathol Jpn 1987, 37(6):887-900.
5. Facchetti F., Vermi W., Mason D., et al. The plasmacytoid monocyte/interferon producing cells. Virchows Arch 2003, 443(6):703-717.
6. Cella M., Jarrossay D., Facchetti F., et al. Plasmacytoid monocytes migrate to inflamed lymph nodes and produce large amounts of type I interferon. Nat Med 1999, 5(8):919-923.
7. Zaba L.C., Fuentes-Duculan J., Steinman R.M., et al. Normal human dermis contains distinct populations of CD11c+BDCA-1+ dendritic cells and CD163+FXIIIA+ macrophages. J Clin Invest 2007, 117(9):2517-2525.
8. Comeau M.R., Van der Vuurst de Vries A.R., Maliszewski C.R., et al. CD123bright plasmacytoid predendritic cells: progenitors undergoing cell fate conversion?. J Immunol 2002, 169(1):75-83.
9. Stout R.D., Suttles J. Functional plasticity of macrophages: reversible adaptation to changing microenvironments. J Leukoc Biol 2004, 76(3):509-513.
10. Han J.W., Shimada K., Ma-Krupa W., et al. Vessel wall-embedded dendritic cells induce T-cell autoreactivity and initiate vascular inflammation. Circ Res 2008, 102(5):546-553.
11. Stein S.L., Paller A.S., Haut P.R., et al. Langerhans cell histiocytosis presenting in the neonatal period: a retrospective case series. Arch Pediatr Adolesc Med 2001, 155(7):778-783.
12. Arico M., Girschikofsky M., Genereau T., et al. Langerhans cell histiocytosis in adults. Report from the International Registry of the Histiocyte Society. Eur J Cancer 2003, 39(16):2341-2348.
13. Pileri S.A., Grogan T.M., Harris N.L., et al. Tumours of histiocytes and accessory dendritic cells: an immunohistochemical approach to classification from the International Lymphoma Study Group based on 61 cases. Histopathology 2002, 41(1):1-29.
14. Zelger B., Cerio R., Orchard G., et al. Juvenile and adult xanthogranuloma. A histological and immunohistochemical comparison. Am J Surg Pathol 1994, 18(2):126-135.
15. Zelger B.W., Sidoroff A., Orchard G., et al. Non-Langerhans cell histiocytoses. A new unifying concept. Am J Dermatopathol 1996, 18(5):490-504.
16. Dziegiel P., Dolilnska-Krajewska B., Dumanska M., et al. Coexpression of CD1a, langerin and Birbeck's granules in Langerhans cell histiocytoses (LCH) in children: ultrastructural and immunocytochemical studies. Folia Histochem Cytobiol 2007, 45(1):21-25.
17. Pinkus G.S., Lones M.A., Matsumura F., et al. Langerhans cell histiocytosis immunohistochemical expression of fascin, a dendritic cell marker. Am J Clin Pathol 2002, 118(3):335-343.
18. Willman C.L., Busque L., Griffith B.B., et al. Langerhans'-cell histiocytosis (histiocytosis X)-a clonal proliferative disease. N Engl J Med 1994, 331(3):154-160.
19. Howarth D.M., Gilchrist G.S., Mullan B.P., et al. Langerhans cell histiocytosis: diagnosis, natural history, management, and outcome. Cancer 1999, 85(10):2278-2290.
20. Yousem S.A., Colby T.V., Chen Y.Y., et al. Pulmonary Langerhans' cell histiocytosis: molecular analysis of clonality. Am J Surg Pathol 2001, 25(5):630-636.
21. Weitzman S., Jaffe R. Uncommon histiocytic disorders: the non-Langerhans cell histiocytoses. Pediatr Blood Cancer 2005, 45(3):256-264.
22. Zelger B., Cerio R., Soyer H.P., et al. Reticulohistiocytoma and multicentric reticulohistiocytosis. Histopathologic and immunophenotypic distinct entities. Am J Dermatopathol 1994, 16(6):577-584.
23. Lu D., Estalilla O.C., Manning J.T., et al. Sinus histiocytosis with massive lymphadenopathy and malignant lymphoma involving the same lymph node: a report of four cases and review of the literature. Mod Pathol 2000, 13(4):414-419.
24. McClain K.L., Natkunam Y., Swerdlow S.H. Atypical cellular disorders. Hematology Am Soc Hematol Educ Program Book 2004, 283-296.
25. Duong A., O'Malley D.P., Barry T.S., et al. Coexistence of Langerhans Cell histiocytosis and Rosai-Dorfman disease: related-disorders?. Mod Pathol 2010, 23(Suppl 1):294A.
26. Bohn O.L., Ruiz-Arguelles G., Navarro L., et al. Cutaneous Langerhans cell sarcoma: a case report and review of the literature. Int J Hematol 2007, 85(2):116-120.
27. Gaertner E.M., Tsokos M., Derringer G.A., et al. Interdigitating dendritic cell sarcoma. A report of four cases and review of the literature. Am J Clin Pathol 2001, 115(4):589-597.
28. Angel C.E., Chen C.J., Horlacher O.C., et al. Distinctive localization of antigen-presenting cells in human lymph nodes. Blood 2009, 113(6):1257-1267.
29. Fonseca R., Yamakawa M., Nakamura S., et al. Follicular dendritic cell sarcoma and interdigitating reticulum cell sarcoma: a review. Am J Hematol 1998, 59(2):161-167.
30. Vos J.A., Abbondanzo S.L., Barekman C.L., et al. Histiocytic sarcoma: a study of five cases including the histiocyte marker CD163. Mod Pathol 2005, 18(5):693-704.
31. van Heerde P., Feltkamp C.A., Hart A.A., et al. Malignant histiocytosis and related tumors. A clinicopathologic study of 42 cases using cytological, histochemical and ultrastructural parameters. Hematol Oncol 1984, 2(1):13-32.
32. Feldman A.L., Arber D.A., Pittaluga S., et al. Clonally related follicular lymphomas and histiocytic/dendritic cell sarcomas: evidence for transdifferentiation of the follicular lymphoma clone. Blood 2008, 111(12):5433-5439.
33. Sun W., Nordberg M.L., Fowler M.R. Histiocytic sarcoma involving the central nervous system: clinical, immunohistochemical, and molecular genetic studies of a case with review of the literature. Am J Surg Pathol 2003, 27(2):258-265.
34. Pileri S.A., Ascani S., Cox M.C., et al. Myeloid sarcoma: clinico-pathologic, phenotypic and cytogenetic analysis of 92 adult patients. Leukemia 2007, 21(2):340-350.
35. Jones D., Dorfman D.M., Barnhill R.L., et al. Leukemic vasculitis: a feature of leukemia cutis in some patients. Am J Clin Pathol 1997, 107(6):637-642.
36. Audouin J., Comperat E., Le Tourneau A., et al. Myeloid sarcoma: clinical and morphologic criteria useful for diagnosis. Int J Surg Pathol 2003, 11(4):271-282.
37. Paydas S., Zorludemir S., Ergin M. Granulocytic sarcoma: 32 cases and review of the literature. Leuk Lymphoma 2006, 47(12):2527-2541.
38. Chaperot L., Perrot I., Jacob M.C., et al. Leukemic plasmacytoid dendritic cells share phenotypic and functional features with their normal counterparts. Eur J Immunol 2004, 34(2):418-426.
39. Khoury J.D., Jedeiros L.J., Manning J.T., et al. CD56(+) TdT(+) blastic natural killer cell tumor of the skin: a primitive systemic malignancy related to myelomonocytic leukemia. Cancer 2002, 94(9):2401-2408.
40. Jaye D.L., Geigerman C.M., Herling M., et al. Expression of the plasmacytoid dendritic cell marker BDCA-2 supports a spectrum of maturation among CD4+ CD56+ hematodermic neoplasms. Mod Pathol 2006, 19(12):1555-1562.
41. Petrella T., Bagot M., Willemze R., et al. Blastic NK-cell lymphomas (agranular CD4+CD56+ hematodermic neoplasms): a review. Am J Clin Pathol 2005, 123(5):662-675.
42. Herling M., Jones D. CD4+/CD56+ hematodermic tumor: the features of an evolving entity and its relationship to dendritic cells. Am J Clin Pathol 2007, 127(5):687-700.
43. Reichard K.K., Burks E.J., Foucar M.K., et al. CD4(+) CD56(+) lineage-negative malignancies are rare tumors of plasmacytoid dendritic cells. Am J Surg Pathol 2005, 29(10):1274-1283.
44. Vermi W., Lonardi S., Bosisio D., et al. Identification of CXCL13 as a new marker for follicular dendritic cell sarcoma. J Pathol 2008, 216(3):356-364.
45. Shia J., Chen W., Tang L.H., et al. Extranodal follicular dendritic cell sarcoma: clinical, pathologic, and histogenetic characteristics of an underrecognized disease entity. Virchows Arch 2006, 449(2):148-158.
46. Pauwels P., Dal Cin P., Vlasveld L.T., et al. A chromosomal abnormality in hyaline vascular Castleman's disease: evidence for clonal proliferation of dysplastic stromal cells. Am J Surg Pathol 2000, 24(6):882-888.
47. Lee I.J., Kim S.C., Kim H.S., et al. Paraneoplastic pemphigus associated with follicular dendritic cell sarcoma arising from Castleman's tumor. J Am Acad Dermatol 1999, 40(2 Pt 2):294-297.
48. Chan A.C., Chan K.W., Chan J.K., et al. Development of follicular dendritic cell sarcoma in hyaline-vascular Castleman's disease of the nasopharynx: tracing its evolution by sequential biopsies. Histopathology 2001, 38(6):510-518.
49. Jones D., Amin M., Ordonez N.G., et al. Reticulum cell sarcoma of lymph node with mixed dendritic and fibroblastic features. Mod Pathol 2001, 14(10):1059-1067.
50. Schuerfeld K., Lazzi S., De Santi M.M., et al. Cytokeratin-positive interstitial cell neoplasm: a case report and classification issues. Histopathology 2003, 43(5):491-494.
51. Andriko J.W., Kaldjian E.P., Tsokos M., et al. Reticulum cell neoplasms of lymph nodes: a clinicopathologic study of 11 cases with recognition of a new subtype derived from fibroblastic reticular cells. Am J Surg Pathol 1998, 22(9):1048-1058.
52. Jaffe R., Pileri S.A., Facchetti F., et al. Histiocytic and dendritic cell neoplasms, introduction. WHO classification of tumours of hematopoietic and lymphoid tissues 2008, 354-355. IARC, Lyon (France). S.H. Swerdlow, E. Campo, N.L. Harris (Eds.).
53. Lin O., Frizzera G. Angiomyoid and follicular dendritic cell proliferative lesions in Castleman's disease of hyaline-vascular type: a study of 10 cases. Am J Surg Pathol 1997, 21(11):1295-1306.
54. Chan J.K., Fletcher C.D., Nayler S.J., et al. Follicular dendritic cell sarcoma. Clinicopathologic analysis of 17 cases suggesting a malignant potential higher than currently recognized. Cancer 1997, 79(2):294-313.
55. Rodig S.J., Payne E.G., Degar B.A., et al. Aggressive Langerhans cell histiocytosis following T-ALL: clonally related neoplasms with persistent expression of constitutively active NOTCH1. Am J Hematol 2008, 83(2):116-121.
56. Greif P.A., Tizazu B., Krause A., et al. The leukemogenic CALM/AF10 fusion protein alters the subcellular localization of the lymphoid regulator Ikaros. Oncogene 2008, 27(20):2886-2896.
57. Nayer H., Murphy K.M., Hawkins A.L., et al. Clonal cytogenetic abnormalities and BCL2 rearrangement in interdigitating dendritic cell sarcoma. Leuk Lymphoma 2006, 47(12):2651-2654.
58. Mohty M., Jarrossay D., Lafage-Pochitaloff M., et al. Circulating blood dendritic cells from myeloid leukemia patients display quantitative and cytogenetic abnormalities as well as functional impairment. Blood 2001, 98(13):3750-3756.